Francisco Javier Gil‐Etayo

Author

Research Institute Hospital 12 de Octubre ORCID

Also Known As

F. J. Gil‐Etayo, Francisco J. Gil-Etayo, Francisco Javier Gil Etayo, Francisco Javier Gil-Etayo, Francisco Javier Gil‐Etayo

Publications

561

Citations

H-Index

Concepts

All Affiliations

Research Institute Hospital 12 de Octubre Hospital Universitario 12 De Octubre Universidad Complutense de Madrid Instituto de Salud Carlos III Centre for Biomedical Network Research on Rare Diseases

About

Francisco Javier Gil‐Etayo is an author at Research Institute Hospital 12 de Octubre specializing in adaptive immunity, immune system, and t cell immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	61
2	Immunology	1	1	61
3	Humoral Immunity	1	1	61
4	Immune Surveillance	1	1	61
5	Immune System	1	1	61

Francisco Javier Gil‐Etayo

Publications

444

Citations

H-Index

Page 1

	Year	Citations
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression Francisco Javier Gil‐Etayo, Patricia Suàrez-Fernández, Óscar Cabrera-Marante, Frontiers in Cellular and Infection Microbiology	2021	159
Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency Daniel Arroyo‐Sánchez, Óscar Cabrera-Marante, Rocío Laguna-Goya, Journal of Clinical Immunology	2021	62
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination Patricia Almendro-Vázquez, Rocío Laguna‐Goya, María Ruiz‐Ruigómez, PLoS Pathogens Adaptive Immune SystemHumoral ResponseImmunologyImmunodominanceImmunotherapeutics	2021	61
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution Francisco Javier Gil‐Etayo, Sara Garcinuño, Alberto Utrero‐Rico, Biomedicines	2022	40
Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss Daniel E. Pleguezuelo, Óscar Cabrera-Marante, Magdalena Abad, Journal of Clinical Medicine	2021	29
Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke Laura Naranjo, Fernando Ostos, Francisco Javier Gil‐Etayo, Frontiers in Cardiovascular Medicine	2021	20
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor Francisco Javier Gil‐Etayo, Sara Garcinuño, Antonio Lalueza, Biomedicines	2021	20
Donor helper innate lymphoid cells are replaced earlier than lineage positive cells and persist long‐term in human intestinal grafts – a descriptive study Elena Gómez‐Massa, María Lasa‐Lázaro, Francisco Javier Gil‐Etayo, Transplant International	2020	12
Next‐generation sequencing identifies four novel <scp>HLA</scp> class I alleles with nucleotide substitutions in the 3′ <scp>UTR</scp> Jairo Eduardo Niño Ramírez, Francisco Javier Gil‐Etayo, Isabel Jiménez Hernaz, HLA	2024	11
Snorting the Brain Away: Cerebral Damage as an Extension of Cocaine-Induced Midline Destructive Lesions Daniel García‐Pérez, Mariano Ruiz-Ortiz, Irene Panero, Journal of Neuropathology & Experimental Neurology	2020	10

Page 1